vimarsana.com

Page 2 - வைப்புத்தொகை பங்கேற்பாளராக News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ED arrests Delhi CA in money laundering case linked to fertiliser scam

ED arrests Delhi CA in money laundering case linked to fertiliser scam
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.

Notification of Amendments to the Applicable Pricing Supplement of the IMRP7 Redeemable Unsecured Listed Programme - SENS

REDEEMABLE UNSECURED LISTED PROGRAMME PREFERENCE SHARES ISSUED BY INVESTEC BANK (MAURITIUS) LIMITED Preference Shareholders of the IMRP7 Preference Shares in relation to the amendments to the IMRP7 applicable pricing supplement, under its ZAR6,000,000,000 Medium Term Note and Preference Share Programme Memorandum. The proposed amendments to the terms of the Preference Shares are as follows: (i) the deletion of clause 24 of the Applicable Pricing Supplement and the insertion of a new clause 24 as follows: accordance with the Modified Following Business Day Convention” (ii) the deletion of clause 28 of the Applicable Pricing Supplement and the insertion of a new clause 28 as follows:

Six suspended Franklin Templeton debt schemes to pay ₹ 2,489 crore this week

Six suspended Franklin Templeton debt schemes to pay ₹ 2,489 crore this week May 03, 2021 These schemes so far have distributed ₹12,084 crore in last two tranches Investors in six suspended schemes of Franklin Templeton will receive ₹ 2,489 crore as part of third tranche of payment this week. So far, these schemes have distributed ₹12,084 crore in last two tranches. We are pleased to inform you that SBI Funds Management would be distributing the next tranche of ₹ 2,488.75 crore to unitholders across all six schemes, Franklin Templeton told distributors. The payment will be made to all investors whose accounts are KYC compliant with all details during the week of May 3, it added.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.